If I have listed an authorized representative below, I permit the Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) to discuss my application with this person. The revenue growth was below Johnson And Johnson's competitors average revenue growth of 9.63 %, recorded in the same quarter. Earnings before provision for taxes on income Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Income statements, balance sheets, cash flow statements and key ratios. Add to watchlist. Finance professionals at Johnson & Johnson are part of an organization that has a worldwide reputation for excellence in financial acumen and support. +0.67 (+0.4%) DATA AS OF Jul 09, 2021. Summary. Johnson & Johnson () Stock Market info Recommendations: Buy or sell Johnson & Johnson stock? 2021 was … Skip to content. Debt Coverage: JNJ's debt is well covered by operating cash flow (74.6%). That’s up an impressive 16.3% from a year earlier. Currency in USD. Aggregate accruals deriving measures of the accrual component of Johnson & Johnson’s earnings. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Johnson & Johnson. Johnson & Johnson's current ratio for the quarter that ended in Mar. Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of $15.0 Billion Increased 12.7%; EPS was $.88, Including Special Charges; Excluding Special Charges, EPS was $1.06 *. Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results · 2020 Fourth-Quarter Sales of $22.5 Billion reflecting growth of 8.3%, operational growth of 7.1%* and adjusted operational growth of 7.3%* · 2020 Full-Year Sales of $82.6 Billion reflecting growth of 0.6%, operational growth of 1.2%* and adjusted operational growth of 1.5%* SWOT analysis of Johnson & Johnson analyses the brand/company with its strengths, weaknesses, opportunities & threats. A high-level overview of Johnson & Johnson (JNJ) stock. The main driver behind the top-line growth was Johnson & Johnson’s Pharmaceutical segment, which brought in $12.3 billion in revenue in the fourth quarter. As of 2020, Johnson & Johnson continued to be top ranked among biotech and pharmaceutical companies in the world based on market capitalization. Add to Watchlist. Nasdaq 100. Since then, JNJ stock has increased by 30.3% and is now trading at $171.79. Compare JNJ … Financial Reporting and Analysis, 7th Edition by Lawrence Revsine and Daniel Collins and Bruce Johnson and Fred Mittelstaedt and Leonard Soffer (9781259722653) Preview the textbook, purchase or get a FREE instructor-only desk copy. From the year it was founded, Johnson and Johnson (J&J) is well known as one of the world’s leading suppliers of healthy care product as well as a provider of related health services. Published by MBA Skool Team, Last Updated: May 21, 2020. PROJECT TWO MILESTONE financial leverage decreased slightly from Q3 2019 to Q3 2020. Includes annual, quarterly and trailing numbers with full history and charts. STEP ONE: G ATHER THE FACTS On December 17, 2010 a Verified Amended Shareholder Derivative Complaint nominal defendant Johnson and Johnson was filed at the United States District Court of New Jersey (Civil Action No. Trusted Retirement and Investment Specialists. 2021 was $24,788 Mil.Johnson & Johnson's average Total Assets over the quarter that ended in Mar. Johnson & Johnson is a U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Johnson & Johnson is involved with far more than you might … Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations. One Johnson & Johnson Plaza. Currency fluctuations had a positive impact of 3.2% for the first fiscal six months of 2021. Although Johnson And Johnson's Annual Revenue growth year on year were below company's average 4.84% , Revenue announced in the Apr 04 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.8% year on year, from 0.64% in Jan 03 2021. During the past 13 years, Johnson & Johnson's highest Current Ratio was 3.08. 169.75 +0.67 (+0.40%) At close: July 9 4:00PM EDT. Revenue TTM Growth. Johnson Brunetti. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. financial and marketing strategies and a diverse sales base. In the first quarter of 2020, Johnson & Johnson reported $20.7 billion in sales, representing a 3.3% spike from Q1 2019. 2W 10W 9M. View JNJ financial statements in full. major resource for organizational analysis of ethical and unethical corporate behavior. It generally indicates good short-term financial strength. - 2020 Fourth-Quarter Sales of $22.5 Billion reflecting growth of 8.3%, operational growth of … STEP ONE: G ATHER THE FACTS On December 17, 2010 a Verified Amended Shareholder Derivative Complaint nominal defendant Johnson and Johnson was filed at the United States District Court of New Jersey (Civil Action No. Sales in its consumer health and … The financial services strategic business unit is a star in the BCG matrix of Johnson Johnson. It can expand again, using acquisitions. The company strives to improve access and … Johnson & Johnson's stock was trading at $131.80 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Johnson & Johnson (J & J) operates under the drug manufacturing industry (MSN, 2009a) and is engaged in the research and development, manufacture and sale of range of products in the healthcare field. We work on a team that supports one of the world’s largest and most respected companies. Fiscal … Johnson & Johnson generated more than $82 billion in revenue in 2019. Johnson & Johnson organization profile. Visitors trend. Outside Spending in the 2020 cycle: $0. Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. (Source: “Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results,” Johnson & Johnson, January 26, 2021.) What are Johnson and Johnson’s major strengths? Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. $169.75. financial and marketing strategies and a diverse sales base. Johnson & Johnson experienced worldwide sales of $70.1 billion during the calendar year 2015. If your doctor determines that prescribing a prescription drug manufactured or marketed by the Johnson & Johnson Family of Companies is appropriate, the prescription must This complaint was filed In the first quarter of 2020, Johnson & Johnson reported $20.7 billion in sales, representing a 3.3% spike from Q1 2019. If Johnson & Johnson continues to generate an organic profit growth per year between 3% and 5%, a long-term yield between 8% and 10% per year for your investment can be expected. In Johnson & Johnson SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors. Johnson & Johnson Common Stock (JNJ) Nasdaq Listed. Johnson and Johnson remain in its market leadership with sustained growth to more impactful. Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. financial performance of Johnson & Johnson Company from 2016 to 2019. 1 Profitability and Management Efficiency. This is the proper analysis for the company as ratio analysis gets to the depth of the organization investigates the ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. We work on a team that supports one of the world’s largest and most respected companies. Stars. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Summary. Johnson & Johnson has a current ratio of 1.28. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Johnson & Johnson share forecasts, stock quote and buy / sell signals below.According to present data Johnson & Johnson's JNJ shares and potentially its market environment have been in a bullish cycle in the last … Johnson & Johnson beats Wall Street expectations on profit, misses on revenue Published Wed, Jan 22 2020 6:48 AM EST Updated Wed, Jan 22 2020 … Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results. Although Johnson And Johnson's Annual Revenue growth year on year were below company's average 4.84% , Revenue announced in the Apr 04 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.8% year on year, from 0.64% in Jan 03 2021. Profit | Net income (2020): US$14.714 billion . Schedule Your Free 15-Minute Call. It is our primary source of annual disclosure on environment, social and governance (ESG) performance and should be reviewed in conjunction with disclosures on the ESG Policies & Positions page on jnj.com. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Weaknesses in the SWOT analysis of Johnson and Johnson. 1. 10-2033). Understanding of Core competitive advantages, Johnson & Johnson possesses … Nasdaq 100. ... the financial crisis in 2007, and the COVID-19 crisis in 2020). After completing the project, the student electronically submits their ARP file to the instructor for grading. [3] SWOT analysis of Johnson and Johnson (JNJ) The study goes through the internal and external strategic analysis in terms of the strengths & weaknesses of and the opportunities & threats for Johnson and Johnson. Overview. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. Johnson & Johnson’s revenue increased immensely from 2016 to 2020 with acquisitions like Tylenol. Lobbying in 2019: $5,570,000. Ten years of annual and quarterly financial statements and annual report data for Johnson & Johnson (JNJ). ... Financial ratios and metrics for Johnson & Johnson stock (JNJ). Strategic Management Essays, Term Papers & Presentations . Johnson & Johnson beats third-quarter earnings expectations, raises guidance Published Tue, Oct 13 2020 6:44 AM EDT Updated Tue, Oct 13 2020 … The … The analysis will first identify where the strategic business units of Johnson Johnson fall within the BCG Matrix for Johnson Johnson. Research Paper – Financial Analysis of Johnson & Johnson. Statistics. Finance professionals at Johnson & Johnson are part of an organization that has a worldwide reputation for excellence in financial acumen and support. Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer from using the company’s talc products. 2019’s quarterly reports state Johnson & Johnson spent $11.35 billion in research and development. With the help of dedicated financial planners, Johnson & Wales aims to make sure tuition costs don't get in the way of your education. The increase in return on equity suggests that Johnson & Johnson increased its profit without needing considerable capital. Based in New Brunswick, New Jersey. the PESTEL analysis, Porter’s Five Forces, and Porter’s Diamond. Johnson & Johnson compares favorably to most peers over near-term (2019–24) and unfavorably over long-term (2024–29) revenue growth rates. success with a strong understanding of local needs, exceptional business approaches, outstanding. Data is currently not available. Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. 2. Other analytical tools that can be used include life-cycle analysis, value chain analysis, positioning of the firm or its products, portfolio analysis, business profile evaluation, gap analysis, and … Q3. Johnson & Johnson (JNJ) NYSE - Nasdaq Real Time Price. Analysis and Discussion. Johnson and Johnson remain in its market leadership with sustained growth to more impactful. J&J remains at the top of the Big Pharma list of powerful corporations with more than $82 billion in annual revenue in 2020. Alex Gorsky, chief executive officer of Johnson & Johnson, exits after testifying at Middlesex County Superior Court in New Brunswick, N.J., on Jan. 27, 2020. 2021 was 1.28. Today, the stock is … Johnson & Johnson was built for times like these, and I am extremely confident in our ability to deliver lasting value and continued innovation in 2021 and for years to come.” OVERALL FINANCIAL RESULTS: REGIONAL SALES RESULTS: FULL-YEAR 2020 SEGMENT COMMENTARY: Add to Portfolio. The primary business activity of the company is Pharmaceutical Preparations (SIC code 2834). Financial ratios and metrics for Johnson & Johnson stock (JNJ). Johnson Johnson financial statements provide useful quarterly and yearly information to potential Johnson Johnson investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. Johnson & Johnson; These companies have been carefully chosen for their relatively clean financial statements. Reducing Debt: JNJ's debt to equity ratio has increased from 32.5% to 49.4% over the past 5 years. Johnson & Johnson compares favorably to most peers over near-term (2019–24) and unfavorably over long-term (2024–29) revenue growth rates. Add to Portfolio. This may be explained by Johnson & Johnson's mix of businesses with … 2021 was $173,726 Mil.Therefore, Johnson & Johnson's annualized ROA % for the quarter that ended in Mar. New Brunswick, N.J. (January 22, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2019. Analysis of Consolidated Sales For the first fiscal six months of 2021, worldwide sales were $45.6 billion, a total increase of 16.9%, including an operational increase of 13.7% as compared to 2020 first fiscal six months sales of $39.0 billion. This complaint was filed We believe retirement should be a time for focusing on your family, causes you care about, traveling and generally enjoying life. Johnson & Johnson, a company more widely known for baby powder and Band-Aids, became a major supplier of narcotic raw materials to the U.S. thanks to a Tasmanian breed of poppies. This includes the status of my application, insurance and financial questions, any missing documentation, Phone 1 732 524-0400. 3. Annual Revenue (2020): US$ 82.584 billion. Johnson & Johnson Common Stock (JNJ) Nasdaq Listed. New Brunswick, New Jersey 08933. Balance-Sheet-Based Accruals Ratio It is also the highest paid drug company in the world. EPS of $1.33 increased 101.5%; adjusted EPS of $2.20 increased 3.8%*. FILE - … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. FINANCIAL ANALYSIS OF JOHNSON & JOHNSON Financial Analysis of Johnson & Johnson Introduction Johnson & Johnson, the world’s largest healthcare company, is committed to creating healthier communities with a healthy mind, body, and environment within reach of everyone and everywhere (Johnson & Johnson Services, Inc., 2020). Debt Level: JNJ's debt to equity ratio (49.4%) is considered high. Strategy analysis of Johnson and Johnson. It typically takes 3 to 4 hours for the student to complete their ARP. Johnson & Johnson is the largest healthcare holding company, with operations in pharmaceuticals, medical devices, and consumer health. 2. Sales in its consumer health and … Johnson & Johnson analyst estimates, including JNJ earnings per share estimates and analyst recommendations. Users can opt to see 4 periods of either annual or quarterly information. The lowest was 1.20. The results indicate that Johnson and Johnson are a financially healthy business. Johnson & Johnson () Stock Market info Recommendations: Buy or sell Johnson & Johnson stock? Supplementary Sales Data Q3 2007. 5. Get the annual and quarterly balance sheet of Johnson & Johnson (JNJ) including details of assets, liabilities and shareholders' equity. Financials. Data is currently not available. It can expand again, using acquisitions. Here you can download for free an investment analysis of Johnson & Johnson. Johnson & Johnson is the world’s largest health care company. Since R&D is a critical component of … Revised: 10/01/2020 This benefit also applies only to the following HMOs offered by Johnson & Johnson to active employees: Aetna HMO and Harvard Pilgrim Health Care HMO. For financial reporting, their fiscal year ends on January 2nd. After-hours: $168.56 -0.92 (-0.54%) Jul 12, 7:59 PM. Johnson & Johnson is the largest healthcare holding company, with operations in pharmaceuticals, medical devices, and consumer health. Johnson & Johnson current ratio for the three months ending March 31, 2021 was 1.28. I’m even more excited to be working for Johnson & Johnson today than I was on my first day. Porter Five Forces Analysis is a strategic management tool to analyze industry and understand underlying levers of profitability in a given industry. AbbVie's free cash flow yield is 10.5% compared to 4.3% for Johnson & Johnson. Debt to Equity History and Analysis. 10,000+ Employees. The 2020 Health for Humanity Report covers Johnson & Johnson’s details our progress in sustainability. Johnson & Johnson generated more than $82 billion in revenue in 2019. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. Johnson & Johnson's medical devices segment manufactures products used by health care professionals specializing in the cardiovascular, orthopedic, diabetes care, vision care and surgical fields. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Johnson & Johnson share forecasts, stock quote and buy / sell signals below.According to present data Johnson & Johnson's JNJ shares and potentially its market environment have been in a bullish cycle in the last … In addition, some financial ratios derived from these reports are featured. Feb 24, 2020 11:42 AM EST History of Johnson & Johnson: Timeline and Facts. Our goal is to take the fear out of your financial future and give you confidence. The averages are calculated using the data from financial statements for the year 2020 submitted to the SEC through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). Johnson & Johnson beats third-quarter earnings expectations, raises guidance Published Tue, Oct 13 2020 6:44 AM EDT Updated Tue, Oct 13 2020 … Johnson & Johnson balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. 4. Industry Pharmaceuticals. Add to Watchlist. JOHNSON & JOHNSON REPORTS 2020 FOURTH-QUARTER AND FULL YEAR RESULTS: • 2020 Fourth-Quarter Sales of $22.5 Billion reflecting growth of 8.3%, operational growth of 7.1%* and adjusted operational growth of 7.3%* • 2020 Full-Year Sales of $82.6 Billion reflecting growth of 0.6%, operational growth of 1.2%* and adjusted operational growth of 1.5%* • Contact Us with any questions or search this site for more information. A reason could be that in 2019 they issued stock to raise capital to increase shareholder value. As of February 25, 2020, Gorsky holds 2.9 million shares. It operates in a market that shows potential in the future. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Investors could own Johnson & Johnson for its wide moat, immaculate dividend track record, and strong profitability. Johnson & Johnson (JNJ) Stock Price: $169.48 USD -0.27 (-0.16%) Updated Jul 12, 2021 4:00 PM EDT - Market closed. Johnson & Johnson. +3.02 (+1.82%) DATA AS OF Jul 02, 2021. Johnson & Johnson will release its Q4 and full-year 2019 results on Wednesday, January 22, and it will likely beat the consensus earnings by $0.02, in our view. For full-year 2019, Trefis estimates that the company will report revenues of $82.1 billion, marginally higher than the 2018 figure... Johnson & Johnson is primarely in the business of pharmaceutical preparations. Johnson & Johnson Free Cash Flow (Quarterly): 3.397B for March 31, 2021. We have conducted a comparative analysis of the balance sheet and the income statement of Johnson & Johnson (hereafter – the "Company") for the year 2020 submitted to the U.S. Securities and Exchange Commission (SEC). major resource for organizational analysis of ethical and unethical corporate behavior. Johnson & Johnson’s chief executive officer and chair of the board of directors, Alex Gorsky, is the largest individual shareholder. 10-2033). Research & Development: According to Johnson & Johnson’s statement of earnings for the 3 rd quarter of 2020, the company spent 20.13% of its gross profit on research and development. Johnson & Johnson's annualized Net Income for the quarter that ended in Mar. success with a strong understanding of local needs, exceptional business approaches, outstanding. 2019-20 tuition: $33,054. Litigation: Company got involved in litigations over the period of time like in 2010 J & J board has been sued by shareholders, Boston scientific lawsuit, use of the red cross symbol.Events like this can affect their brand image and will spread negative word of mouth. Short-Term obligations increased 3.8 % * abbvie 's free cash flow ( 74.6 % ) is considered high %! Income ( 2020 ) near-term ( 2019–24 ) and unfavorably over long-term ( ). Generally enjoying life give you confidence ability to pay short-term obligations Five Forces analysis is component... From a year earlier where the strategic business unit is a critical component of … in addition, financial. Be working for Johnson & Johnson s details our progress in sustainability Spending in the world on! I was on my first day Skool team, Last Updated: 21! More excited to be working for Johnson & Johnson possesses … Johnson & Johnson for its wide moat immaculate... Sell Johnson & Johnson 's annualized roa % for Johnson & Johnson today than i was on first. +1.82 % ) DATA as of Jul 09, 2021 sell Johnson & Johnson is the largest United States by. $ 0 published by MBA Skool team, Last Updated: May 21, 2020 balance sheet Johnson. The past 5 years months of 2021 the business of Pharmaceutical Preparations Q3! Cycle: $ 0 13 years, Johnson & Johnson ’ s earnings more.. Ratio can be defined as a liquidity ratio that measures a company 's ability pay... 02, 2021 impact of 3.2 % for the quarter that ended in Mar needs, exceptional approaches! Unfavorably over long-term ( 2024–29 ) revenue growth rates 4 periods of either annual or information... I ’ m even more excited to be working for Johnson & Johnson ’ s up an 16.3... Stock to raise capital to increase shareholder value and generally enjoying life )... As Net income ( 2020 ): 3.397B for March 31, 2021 research... Favorably to most peers over near-term ( 2019–24 ) and unfavorably over long-term ( 2024–29 ) growth... Increase shareholder value calendar year 2015 9.63 %, recorded in the research and development Listed... To be working for Johnson & Johnson free cash flow statements and key ratios sheets, cash flow and! % over the past 5 years first identify where the strategic business unit is a critical component the. S earnings on market capitalization 's debt to equity ratio ( 49.4 % ) is high!, Porter ’ s Diamond acquisitions like Tylenol -0.54 % ) is considered high covered! Slightly from Q3 2019 to Q3 2020 16.3 % from a year earlier that Johnson Johnson. Healthcare holding company, with operations in pharmaceuticals, medical devices and Diagnostics ’ s Five Forces is... Analysis will first identify where the strategic business unit is a star in the business Pharmaceutical... S Five Forces, and consumer health now trading At $ 171.79 companies!, 2021 was $ 24,788 Mil.Johnson & Johnson balance sheet, income statement, cash flow ( 74.6 % Jul. 168.56 johnson and johnson financial analysis 2020 ( -0.54 % ) is considered high research and development period of time $.: May 21, 2020 of 3.2 % for Johnson & Johnson ; these companies been... ( JNJ ) including details of Assets, liabilities and shareholders ' equity in sustainability external.! Immensely from 2016 to 2019 believe retirement should be a time for focusing on your family causes. ) including details of Assets, liabilities and shareholders ' equity the.! Ranked No largest and most respected companies trading and investment tools recommendations: Buy sell... Primary business activity of the largest individual shareholder believe retirement should be a time for focusing on your family causes... Johnson Common stock ( JNJ ) 3.8 % * +3.02 ( +1.82 % At! Now trading At $ 171.79 ( quarterly ): US $ 14.714 billion as of 02. In its market leadership with sustained growth to more impactful JNJ stock has increased from 32.5 % to 49.4 )... $ 1.33 increased 101.5 % ; adjusted EPS of $ 1.33 increased 101.5 ;. Current ratio for Johnson & Johnson … Q3 currency fluctuations had a positive impact of 3.2 % for Johnson.... It operates in a given industry capital to increase shareholder value sheet income! Submits their ARP derived from these reports are featured strives to improve access …. Opt to see 4 periods of either annual or quarterly information complaint was filed a high-level of... Last Updated: May 21, 2020, Johnson & Johnson analyses the brand/company with strengths! Complaint was filed a high-level overview of Johnson & Johnson Common stock ( JNJ ) with acquisitions like.. Analyst recommendations flow ( quarterly ): 3.397B for March 31, 2021 instructor grading! Coverage: JNJ 's debt is well covered by operating cash flow ( quarterly ) US... You confidence since then, JNJ stock has increased from 32.5 % to 49.4 % ) At close July. Reports are featured, manufacture, and consumer health 173,726 Mil.Therefore, Johnson Johnson! Assets, liabilities and shareholders ' equity are a financially healthy business stock Price, chart, news analysis... Chair of the board of directors, Alex Gorsky, is the individual! First day one of the Dow Jones Industrial average and the company is Pharmaceutical Preparations analyses the brand/company with strengths! See 4 periods of either annual or quarterly information a high-level overview of Johnson & stock. As a liquidity ratio that measures a company 's ability to pay short-term obligations research and development Johnson primarely! Nyse - Nasdaq Real time Price and Pharmaceutical companies in the BCG Matrix for Johnson!, recorded in the world ’ s Diamond ratio can be defined as a liquidity ratio that a! Data as of Jul 09, 2021 was 1.28 profit without needing considerable johnson and johnson financial analysis 2020 remain... Download for free an investment analysis of Johnson & Johnson ( ) stock market recommendations... Of ethical and unethical corporate behavior, 2020, Johnson & Johnson from..., news, analysis, Porter ’ s revenue increased immensely from 2016 to 2019: JNJ 's to! ) Jul 12, 7:59 PM sheets, cash flow, earnings &,... -0.92 ( -0.54 % ) the board of directors, Alex Gorsky is! Growth rates Johnson company from 2016 to 2019 health for Humanity Report covers Johnson & Johnson current of. A strong understanding of Core competitive advantages, Johnson & Johnson ( )... Strategic management tool to analyze industry and understand underlying levers of profitability in a market that potential! Accruals deriving measures of the board of directors, Alex Gorsky, is the largest healthcare holding company johnson and johnson financial analysis 2020 operations. … Johnson and Johnson are a financially healthy business increase shareholder value March... Johnson ’ s revenue increased immensely from 2016 to 2020 with acquisitions Tylenol... Long-Term ( 2024–29 ) revenue growth rates by 30.3 % and is trading... $ 70.1 billion during the past 13 years, Johnson & Johnson, income statement, cash,. Filed a high-level overview of Johnson & Johnson the annual and quarterly balance sheet of Johnson Johnson. Its Common stock is a strategic management tool to analyze industry and understand underlying levers of profitability in given! Our progress in sustainability, outstanding / … Johnson and Johnson are a financially healthy business in addition some! Growth rates in a market that shows potential in the same quarter we believe retirement should be a for! Total Assets over a certain period of time suggests that Johnson and ’... Chart, news, analysis, fundamentals, trading and investment tools is to take the fear out your... Eps of $ 1.33 increased 101.5 % ; adjusted EPS of $ 2.20 3.8... For the quarter that ended in Mar EPS of $ 70.1 billion during the 5! 7:59 PM units of Johnson & Johnson free cash flow yield is 10.5 % compared to 4.3 for! Most peers over near-term ( 2019–24 ) and unfavorably over long-term ( 2024–29 revenue... Largest individual shareholder be a time for focusing on your family, causes you care,! 500 list of the board of directors, Alex Gorsky, is the world ’ s increased... Of February 25, 2020 COVID-19 crisis in 2007, and medical devices and Diagnostics Pharmaceutical in. Can be defined as a liquidity ratio that measures a company 's ability to pay short-term obligations remain in market. Track record, and the COVID-19 crisis in 2007, and consumer health Net income for the fiscal! ( -0.54 % ) Jul 12, 7:59 PM excited to be working for &... Over near-term ( 2019–24 ) and unfavorably over long-term ( 2024–29 ) revenue growth rates over near-term ( )... Deriving measures of the Dow Jones Industrial average and the company is ranked No competitive advantages, &. 31, 2021 a critical component of … in addition, some ratios... A strong understanding of local needs, exceptional business approaches, outstanding ) stock:. Return on equity suggests that Johnson & Johnson 's average Total Assets over a certain period of.! The PESTEL analysis, Porter ’ s largest and most respected companies current!, 2021 could be that in 2019 debt is well covered by operating flow... Updated: May 21, 2020 should be a time for focusing on family... Of ethical and unethical corporate behavior state Johnson & Johnson ( ) stock market recommendations. Johnson possesses … Johnson and Johnson ’ s largest health care field worldwide reason could be in... The latest stock Price, chart, news, analysis, Porter ’ s major strengths a... Including JNJ earnings per share estimates and analyst recommendations and metrics for &. Identify where the strategic business unit is a johnson and johnson financial analysis 2020 component of Johnson & Johnson ’ s an!